NYSE:MMS

Maximus (MMS) Stock Price, News & Analysis

$87.13
+0.11 (+0.13%)
(As of 05/16/2024 ET)
Today's Range
$86.57
$87.89
50-Day Range
$79.78
$87.13
52-Week Range
$72.39
$90.65
Volume
224,282 shs
Average Volume
333,828 shs
Market Capitalization
$5.30 billion
P/E Ratio
22.87
Dividend Yield
1.38%
Price Target
$102.00

Maximus MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
17.1% Upside
$102.00 Price Target
Short Interest
Healthy
0.83% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.03mentions of Maximus in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
0.17%
From $5.85 to $5.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.60 out of 5 stars

Business Services Sector

112th out of 319 stocks

Business Services, Not Elsewhere Classified Industry

45th out of 91 stocks

MMS stock logo

About Maximus Stock (NYSE:MMS)

Maximus, Inc. operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The U.S. Federal Services segment offers Business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The Outside the U.S. segment offers BPS solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.

MMS Stock Price History

MMS Stock News Headlines

Maximus earnings: here's what to expect
Maximus: Fiscal Q2 Earnings Snapshot
Maximus, Inc. (MMS)
Maximus Values Icon Award Winner: Dianne Henderson
MAXIMUS declares $0.30 dividend
See More Headlines
Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/29 Dividend
2/14/2024
Dividend Payable
2/29/2024
Last Earnings
5/08/2024
Ex-Dividend for 5/31 Dividend
5/14/2024
Today
5/16/2024
Dividend Payable
5/31/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
39,600
Year Founded
1975

Price Target and Rating

Average Stock Price Target
$102.00
High Stock Price Target
$102.00
Low Stock Price Target
$102.00
Potential Upside/Downside
+17.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$161.79 million
Pretax Margin
6.01%

Debt

Sales & Book Value

Annual Sales
$4.90 billion
Cash Flow
$6.51 per share
Book Value
$29.43 per share

Miscellaneous

Free Float
59,945,000
Market Cap
$5.30 billion
Optionable
Optionable
Beta
0.72

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives


MMS Stock Analysis - Frequently Asked Questions

Should I buy or sell Maximus stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MMS shares.
View MMS analyst ratings
or view top-rated stocks.

What is Maximus' stock price target for 2024?

2 analysts have issued 12 month price targets for Maximus' shares. Their MMS share price targets range from $102.00 to $102.00. On average, they expect the company's stock price to reach $102.00 in the next twelve months. This suggests a possible upside of 17.1% from the stock's current price.
View analysts price targets for MMS
or view top-rated stocks among Wall Street analysts.

How have MMS shares performed in 2024?

Maximus' stock was trading at $83.86 at the beginning of 2024. Since then, MMS stock has increased by 3.9% and is now trading at $87.13.
View the best growth stocks for 2024 here
.

When is Maximus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our MMS earnings forecast
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) released its earnings results on Wednesday, May, 8th. The health services provider reported $1.57 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.26. The health services provider earned $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a trailing twelve-month return on equity of 18.02% and a net margin of 4.58%. The firm's revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.80 EPS.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Friday, April 5th. Investors of record on Wednesday, May 15th will be given a dividend of $0.30 per share on Friday, May 31st. This represents a $1.20 annualized dividend and a dividend yield of 1.38%. The ex-dividend date is Tuesday, May 14th.
Read our dividend analysis for MMS
.

Is Maximus a good dividend stock?

Maximus (NYSE:MMS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.41%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 31.50%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 20.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

What guidance has Maximus issued on next quarter's earnings?

Maximus issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of 5.650-5.850 for the period, compared to the consensus EPS estimate of 4.290. The company issued revenue guidance of $5.2 billion-$5.3 billion, compared to the consensus revenue estimate of $5.2 billion.

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Who are Maximus' major shareholders?

Maximus' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.17%), Janus Henderson Group PLC (2.06%), Allspring Global Investments Holdings LLC (1.16%), Allspring Global Investments Holdings LLC (1.16%), William Blair Investment Management LLC (0.72%) and Public Employees Retirement Association of Colorado (0.55%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michael J Warren, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Teresa Weipert.
View institutional ownership trends
.

How do I buy shares of Maximus?

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MMS) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners